SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020088
Filing Date
2023-05-10
Accepted
2023-05-10 07:31:07
Documents
61
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tcrt-20230331.htm   iXBRL 10-Q 1777504
2 EX-10.1 tcrt-ex10_1.htm EX-10 405738
3 EX-10.2 tcrt-ex10_2.htm EX-10 27331
4 EX-10.3 tcrt-ex10_3.htm EX-10 39216
5 EX-10.4 tcrt-ex10_4.htm EX-10 189843
6 EX-31.1 tcrt-ex31_1.htm EX-31 16560
7 EX-32.1 tcrt-ex32_1.htm EX-32 8754
8 GRAPHIC img42087188_0.jpg GRAPHIC 5744
  Complete submission text file 0000950170-23-020088.txt   7043217

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcrt-20230331.xsd EX-101.SCH 58573
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcrt-20230331_pre.xml EX-101.PRE 353093
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcrt-20230331_def.xml EX-101.DEF 268568
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcrt-20230331_lab.xml EX-101.LAB 465223
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcrt-20230331_cal.xml EX-101.CAL 29803
55 EXTRACTED XBRL INSTANCE DOCUMENT tcrt-20230331_htm.xml XML 778064
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 23904348
SIC: 2834 Pharmaceutical Preparations